Loading...
NPI 1689340267 · Tampa, FL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Gh Labb LLC is a clinical medical laboratory provider located in Tampa, Florida. This profile covers 5 Medicare and 26 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Gh Labb LLC |
| Address | 6302 Benjamin Rd Ste 400 |
| City | Tampa |
| State | FL |
| ZIP | 33634 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | August 23, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.2M |
| Medicaid | $198.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2,980 | $150 | $455.3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2,710 | $110 | $303.1K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,250 | $200 | $243.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 2,960 | $60 | $180.6K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 30 | $240 | $6K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
26 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3,310 | $20 | $62.9K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 5,460 | $10 | $38.2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3,040 | $10 | $27.3K |
| 80365 | The lab analyst measures the amount of or detects the presence of oxycodone, a synthetic opioid pain medication, in a patient specimen. | 3,130 | $1 | $12.5K |
| 80363 | The lab analyst measures the amount of or detects the presence of three or four opioids and opiate analogs, narcotic analgesics that depress the central nervous system, in the specimen. | 730 | $10 | $10.2K |
| 80361 | The lab analyst measures the amount of or detects the presence of one or more opiates, narcotic analgesics that depress the central nervous system, in the specimen. | 3,880 | $1 | $7.8K |
| 80354 | The lab analyst measures the amount of or detects the presence of fentanyl in the patient specimen. | 1,050 | $1 | $4.2K |
| 80348 | The lab analyst measures the amount of or detects the presence of buprenorphine in a patient specimen. Buprenorphine is a drug used to treat opioid addiction, to control acute pain in individuals who… | 940 | $1 | $3.8K |
| 80373 | The lab analyst measures the amount of or detects the presence of tramadol, which is a centrally acting opioid pain medication, in the patient specimen. | 880 | $1 | $3.5K |
| 80358 | The lab analyst measures the amount of or detects the presence of methadone in the patient specimen. | 870 | $1 | $3.5K |
Showing 1–10 of 26
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
26 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 17 | 50 | 360 | $40 | $96.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 78 | 450 | 1,380 | $20 | $75.1K |
| 80324 | The lab analyst measures the amount of or detects the presence of one or two amphetamines, a central nervous system stimulant in a patient specimen. | 18 | 30 | 420 | $20 | $45K |
| 80346 | The lab analyst measures the amount of or detects the presence of one to twelve benzodiazepines, which are tranquilizers, in a patient specimen. | 19 | 30 | 1,240 | $10 | $28.2K |
| 80361 | The lab analyst measures the amount of or detects the presence of one or more opiates, narcotic analgesics that depress the central nervous system, in the specimen. | 11 | 30 | 2,210 | $1 | $27.3K |
| 80365 | The lab analyst measures the amount of or detects the presence of oxycodone, a synthetic opioid pain medication, in a patient specimen. | 10 | 30 | 1,230 | $1 | $26.1K |
| 80321 | The lab analyst detects and measures the alcohol biomarker in a patient specimen. Alcohol biomarkers are physiological indicators of the alcohol exposure or ingestion. In this test, the analyst tests… | 17 | 20 | 1,040 | $10 | $25.4K |
| 80348 | The lab analyst measures the amount of or detects the presence of buprenorphine in a patient specimen. Buprenorphine is a drug used to treat opioid addiction, to control acute pain in individuals who… | 17 | 40 | 380 | $1 | $23.9K |
| 80370 | The lab analyst measures the amount of or detects the presence of three or more skeletal muscle relaxants in the patient specimen. These drugs reduce the tone of skeletal muscles and thus alleviate… | 18 | 20 | 1,140 | $1 | $22.8K |
| 80372 | The lab analyst measures the amount of or detects the presence of tapentadol, a centrally acting opioid pain medication, in the patient specimen. | 12 | 20 | 760 | $1 | $22.5K |
Showing 1–10 of 26
Other providers in the same ZIP code as Gh Labb LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Option Care Enterprises, Inc. | FL | Home Infusion Therapy Pharmacy | $0 | $29.3M |
| Families First Of Florida LLC | FL | Community/Behavioral Health Agency | $0 | $25.4M |
| Carecentrix, Inc. | FL | Case Management Agency | $0 | $13.7M |
| Bioscrip Infusion Services, LLC | FL | Home Infusion Therapy Pharmacy | $0 | $12.5M |
| Ruffolo Hooper & Associates Md PA | FL | Anatomic Pathology & Clinical Pathology Physician | $0 | $10.1M |
| Eye Doctors Optical Outlets PA | FL | Optometrist | $0 | $9.2M |
| Physicians Toxicology Laboratory, LLC | FL | Clinical Medical Laboratory | $1.6M | $6.1M |
| Delivrxd LLC | FL | Community/Retail Pharmacy | $4.3M | $1.9K |
| Infiniti Labs, Inc | FL | Clinical Medical Laboratory | $798.4K | $2.5M |
| Apex Labs, Inc | FL | Clinical Medical Laboratory | $427.3K | $1.6M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.